Skip to contentSkip to Braille Studio

Library / Laws / 114th Congress / House Bills / H.R. 2337

H.R. 2337

To amend the Federal Food, Drug, and Cosmetic Act to authorize priority review for breakthrough devices.

Print stageDateSize⠃
Introduced in House2015-05-148.4K⠃⠗⠋